Published in Vaccine Weekly, April 14th, 1997
Licensure of Tetracel has been sought for use in toddlers at 12 to 18 months of age for immunization against four serious childhood illnesses - diphtheria, tetanus, pertussis, and Haemophilus influenzae type b or Hib disease.
Tetracel is a combination vaccine comprised of four components contained in Wyeth-Lederle's two currently marketed vaccines - Acel-Imune Diphtheria and Tetanus Toxoids and Acellular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.